Display search results for ** instead (6 products)
16 Feb 2017  |  North America
Value-based Care to Push Deployment of Sophisticated Outcomes-based Compensation Models, Driving Need for Consumer-centric Targeted Therapies
In this research deliverable, Frost & Sullivan’s senior analyst team provides bold perspectives and predictions for the global healthcare industry in 2017. The markets covered include pharmaceuticals and biotech, in-vitro diagnostics, medical devices, medical imaging, and healthcare IT. The analysis captures the impact of trends that are expected...
10 Jan 2020  |  North America
A Decade of Change for Healthcare—Access to Key Predictions and Growth Opportunities
Amid rising global trade tensions and sluggish global economic outlook for 2020, the global healthcare market is expected to cross the $2 trillion mark in 2020. Healthcare will be among the top two priorities for voters in the 2020 presidential election in the US. In the European region, looming BREXIT indecision is likely to have a strong impact o...
USD 4,455.00 save 10 %
10 Jul 2018  |  North America
Cybersecurity, Artificial Intelligence, Virtual Care, Digital Therapeutics, and the Movements of Major Tech Companies Continue to Advance the Market
At the beginning of this decade, Frost & Sullivan invented the definition of Digital Health to include convergent market segments, such as healthcare information technology (HCIT), remote patient monitoring (RPM), mobile health (mHealth), and telemedicine. Over the last five years, these segments have become increasingly sophisticated as new techno...
03 Jan 2018  |  North America
Value-based Care Will Continue to Drive Growth Opportunities for Emerging Technologies as They Move Out form Pilot Testing into Production Environments
In this research deliverable, Frost & Sullivan provides bold perspectives and predictions for the global healthcare industry in 2018. The markets covered include pharmaceuticals and biotech, in-vitro diagnostics, medical technologies, medical imaging, and healthcare IT. The analysis captures sectoral and regional trends and provides predictions for...
09 Apr 2018  |  North America
Global Life Sciences Industry to Reach $1.5 T by 2022, Driven by Innovative Google, Amazon, Facebook, Apple (GAFA) Partnerships and R&D IT Investments
The global life sciences industry is onto a rocking start with the surge in CEO confidence from US tax reforms, rollicking equity markets and strengthening the global economy. Healthcare digitization, democratization creating explosion in patient data, emergence of value-based reimbursement models, and healthcare consumerism shifting the risk from ...
26 Dec 2018  |  North America
With the Rise in Focus on Value-based Care, Technology Convergence will Drive Care Delivery Innovation
Globally, 2019 will be a year of value-based care, as ‘outcome-based care’ focus will globalize. This will trigger the maturation of risk-sharing in solution contracting between providers and drug/device OEMs, driving business value for providers. Access to affordable and quality care will be key political agendas for the upcoming 2019 election...